Genetic Testing for Antipsychotic Pharmacotherapy: Bench to Bedside
There is growing research interest in learning the genetic basis of response and adverse effects with psychotropic medications, including antipsychotic drugs. However, the clinical utility of information from genetic studies is compromised by their controversial results, primarily due to relatively...
Main Author: | Mujeeb U. Shad |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Behavioral Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-328X/11/7/97 |
Similar Items
-
Pharmacoeconomic assessment of antipsychotic treatment in outpatients with schizophrenia
by: I. A. Vilyum, et al.
Published: (2018-05-01) -
Pharmacoeconomic analysis of using typical and atypical antipsychotics in schizophrenia
by: I. A. Vilyum, et al.
Published: (2018-08-01) -
Effects of zinc sulfate on schizophrenia symptoms in patients undergoing atypical antipsychotic pharmacotherapy
by: Forouzan Behrouzian, et al.
Published: (2022-01-01) -
Comparison of antipsychotic prescribing practices following failure of antipsychotic monotherapy in the acute care setting
by: Kaitlyn Morgan, PharmD, BCPP, et al.
Published: (2023-01-01) -
Unlocking the molecular mechanisms of antipsychotics – a new frontier for discovery
by: Heather Bowling, et al.
Published: (2016-07-01)